Fetal Bovine Serum Market Size by Application, End User, Product, Region, Industry-Wide Analysis, Competitive Landscape Assessment & Long-Term Forecast to 2034
Overview
Fetal Bovine Serum Market size is expected to reach US$ 1.62 Bn. by year 2034 at a CAGR of 5.3% during the forecast period.
Fetal Bovine Serum Market Size, Growth & Share Analysis
To know about the Research Methodology :- Request Free Sample Report
The development in research and academic initiatives by the private and governmental sector is expected to drive the market growth. The research and development activities and the expansion of the product portfolio, which is expected to enhance the growth of the market in the next few years. Also, a significant increase in the number of academic research institutes is expected to encourage the growth of the global fetal bovine serum market during the forecast period.
The rising initiative from governments, who are coming together with academic research institutes in order to encourage and support the research activities is further expected to accelerate the growth of the market in the near future.The report study has analyzed revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers and market disrupters in the report and same is reflected in our analysis.
Furthermore, the rapid growth of the pharmaceutical, biotechnology, and animal health industries is likely to generate potential growth opportunities for the market players in the next few years. Additionally, the growing demand from traditional users of serum is also expected to boost the growth of the market. As fetal bovine serum has a higher efficiency rate than normal blood serum it is expected to drive the growth of the overall serum market.
Also, the increasing number of collaborations and mergers and acquisitions is projected to generate good opportunities for the market players. At the same time, decrease in cattle herd population due to the increased demand for dairy and meat products, and high cost and chances of viral presence in the product these factors are expected to limiting the market growth.
According to the end user, the fetal bovine serum industry is bifurcated into biotechnology & pharmaceutical company, academic institute and research laboratory. Biotechnology & pharmaceutical company segment accounted for the highest revenue in 2025 and is expected to grow at the fastest CAGR during the forecast period. This is attributed to the increased R&D and production of vaccines as well as biopharmaceuticals in these companies.
Among the regions, North America is expected to hold the largest market share for fetal bovine serum. The high consumption and high pricing of fetal bovine serum in this region. The increasing demand, together with a lower supply has led to a volatile market for the U.S. The rapid arrival of contract research organizations particularly in India and China is a key factor driving the growth of Asia-Pacific region. Furthermore, Infrastructural development and number of research organizations are outsourcing research activities to these countries for a relatively low cost without negotiating on the quality of research.
The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding the global fetal bovine serum market dynamics, structure by identifying and analysing the market segments and project the global market size.
Further, the report also focuses on the competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER’s analysis, and SWOT analysis to address questions of shareholders to prioritizing the efforts and investment in the near future to the emerging segment in the global fetal bovine serum market.
Fetal Bovine Serum Market Recent Development
| Date | Company | Development | Impact |
|---|---|---|---|
| 12 May 2025 | PL BioScience | Launched the world’s first artificial Human Platelet Lysate (HPL) as a lab-made alternative to fetal bovine serum. | Provides a xeno-free substitute for pharmaceutical bioprocessing, reducing dependence on animal-derived components. |
| 15 June 2025 | Cytiva | Announced a USD 1.6 billion expansion of single-use bioreactor production capacity to support scalable biologics manufacturing. | Increases the long-term demand for high-quality serum and serum-supplemented media in seed-train maintenance. |
| 10 November 2025 | Wacker Chemie AG | Launched FGF-2 Food, a microbially-fermented recombinant growth factor designed for animal-component-free cell culture. | Enables the production of cultivated meat and cell-based products without relying on traditional fetal bovine serum. |
| 05 January 2026 | Merck KGaA | Finalized the integration of Mirus Bio technologies following a USD 290 million acquisition to advance defined media platforms. | Strengthens the shift toward chemically defined media, providing alternatives to serum-based research workflows. |
Fetal Bovine Serum Market Scope: Inquire before buying
| Global Fetal Bovine Serum Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2025 | Forecast Period: | 2026-2034 |
| Historical Data: | 2020 to 2025 | Market Size in 2025: | US $ 1.02 Bn. |
| Forecast Period 2026 to 2034 CAGR: | 5.3% | Market Size in 2034: | US $ 1.62 Bn. |
| Segments Covered: | by Application | Biopharmaceuticals Cell Culture Drug Discovery Diagnostics In Vitro Fertilization Human & Animal Vaccine Production Others |
|
| by End User | Biotechnology & Pharmaceutical Companies Academic Institute Industry Research Laboratory |
||
| by Product | Charcoal Stripped Chromatographic Dialyzed Fetal Bovine Serum (FBS) Exosome Depleted Stem Cell Embryonic Stem Cells Qualified Mesenchymal Stem Cell Qualified |
||
Fetal Bovine Serum Market, by Region:
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Fetal Bovine Serum Market Key Players:
1. GE Healthcare
2. Merck KGaA (Sigma Aldrich)
3. HiMedia Laboratories Pvt., Ltd.
4. Bio-Techne
5.Biowest
6. Biological Industries
7. Atlas Biologicals
8. Rocky Mountain Biologicals
9. PAN-Biotech
10. Thermo Fisher Scientific Inc.
11. Takara Bio, Inc.
12. Tissue Culture Biologicals
13. Caisson Laboratories, Inc.
14. Cell Culture Technologies LLC
15. Biomol GmbH
16. BovogenBiologicals Pty Ltd
17. TCS Biosciences Ltd
18. Access Biologicals
19. Animal Technologies Inc.
20. Corning Incorporated
Frequently Asked Questions:
1. Which region has the largest share in Global Fetal Bovine Serum Market?
Ans: North America region holds the highest share in 2025.
2. What is the growth rate of Global Fetal Bovine Serum Market?
Ans: The Global Fetal Bovine Serum Market is growing at a CAGR of 5.3% during forecasting period 2026-2034.
3. What is scope of the Global Fetal Bovine Serum market report?
Ans: Global Fetal Bovine Serum Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.
4. Who are the key players in Global Fetal Bovine Serum market?
Ans: The important key players in the Global Fetal Bovine Serum Market are – GE Healthcare, Merck KGaA (Sigma Aldrich), HiMedia Laboratories Pvt., Ltd., Bio-Techne, Biowest, Biological Industries, Atlas Biologicals, Rocky Mountain Biologicals, PAN-Biotech, Thermo Fisher Scientific Inc., Takara Bio, Inc., Tissue Culture Biologicals, Caisson Laboratories, Inc., Cell Culture Technologies LLC, Biomol GmbH, BovogenBiologicals Pty Ltd, TCS Biosciences Ltd, Access Biologicals, Animal Technologies Inc., Corning Incorporated, Tissue Culture Biologicals, and Cytiva.
5. What is the study period of this market?
Ans: The Global Fetal Bovine Serum Market is studied from 2020 to 2034.